Literature DB >> 3016076

Poliovirus antibody in Northern Greece.

V Kyriazopoulou-Dalaina.   

Abstract

In order to study the serological status of the Northern Greek population to poliovirus, 881 sera from healthy people were examined for neutralizing antibody by the micrometabolic inhibition test. The people under examination were aged from 1 day to 70 years old. Overall, of the 881 sera examined, 704 (80%) had antibodies (titre greater than or equal to 4) to poliovirus 1, 742 (84%) had antibodies to poliovirus 2 and 715 (81%) had antibodies to poliovirus 3. Fifty-five per cent of the sera had antibodies to all three polioviruses while 3.3% had no poliovirus antibody at all. There was no statistically significant difference in the rates of seropositivity to the various poliovirus types or between males and females. However the rates of seropositivity did vary with age.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016076      PMCID: PMC2129705          DOI: 10.1017/s0022172400066274

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  8 in total

1.  Seroimmunity to polioviruses in U.S. Army recruits.

Authors:  D S Burke; J C Gaydos; R A Hodder; W H Bancroft
Journal:  J Infect Dis       Date:  1979-02       Impact factor: 5.226

2.  Seroimmunity to poliomyelitis in an American community.

Authors:  T R Oberhofer; G C Brown; A S Monto
Journal:  Am J Epidemiol       Date:  1975-04       Impact factor: 4.897

3.  Persistence of antibodies in a population immunized with oral poliovaccine (OPV).

Authors:  H Srámová; V Teplý; E Svandová
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1979

4.  A micrometabolic inhibition test for the estimation of poliovirus neutralizing antibodies.

Authors:  V G Kyriazopoulou; E J Bell
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

5.  [Serological control over the state of immunity to the poliomyelitis virus in children].

Authors:  A S Kaplan; N I Vasilevskaia; I N Kozhevnikov; G S Stepanova
Journal:  Vopr Virusol       Date:  1974 Jul-Aug

6.  Poliomyelitis: A gap in immunity?

Authors:  D Reid; E J Bell; N R Grist; T S Wilson
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

7.  Seroepidemiology of the poliovirus in Monrovia (Liberia).

Authors:  A Rodriguez-Burgos; J L Bada; J L Fernandez-Calvo; V M Artola
Journal:  Trans R Soc Trop Med Hyg       Date:  1977       Impact factor: 2.184

8.  [Immunity against poliomyelitis in the German Federal Republic (author's transl)].

Authors:  H W Doerr; H Glück; I Esser; R Firtzlaff; I Koch; G Maass; G May; H Meier-Ewert; D Neumann-Haefelin; O Thraenhart; I Wecker
Journal:  Dtsch Med Wochenschr       Date:  1979-07-27       Impact factor: 0.628

  8 in total
  3 in total

1.  Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum.

Authors:  M L Tanzi; P Colotto; M Vignali; P Affanni; U Bracchi; E Bellelli
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Serum antibodies to polioviruses in a Tuscan population, Italy.

Authors:  D Reali; A Carducci; M A Ruschi
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

Review 3.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.